SUDARSHANA BORAH KHANIKOR | PHYTOCHEMISTRY | Women Researcher Award

Assoc. Prof. Dr. SUDARSHANA BORAH KHANIKOR | PHYTOCHEMISTRY | Women Researcher Award

ASSOCIATE PROFESSOR at THE ROYAL SCHOOL OF PHARMACY, THE ASSAM ROYAL GLOBAL UNIVERSITY, India

Dr. Sudarshana Borah is a distinguished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Royal Global University. With a Ph.D. from Dibrugarh University, her research expertise encompasses natural products, pharmacology, and microbiology. Dr. Borah has made significant contributions to the scientific community, authoring numerous publications that have garnered over 494 citations, reflecting the impact of her work. Her dedication to advancing pharmaceutical education is evident through her roles as Vice Principal and Associate Professor at the School of Pharmaceutical Sciences, University of Science and Technology, Meghalaya (USTM), where she also coordinated the Internal Quality Assurance Cell (IQAC) and managed various academic and administrative responsibilities. Dr. Borah’s commitment to research excellence and education has been recognized through multiple awards, including the International Young Scientist Award in 2019. Her multifaceted career reflects a blend of scholarly achievement, leadership, and a passion for fostering innovation in pharmaceutical sciences.

Professional Profile

Education

Dr. Borah’s academic journey is marked by a series of notable achievements. She earned her Bachelor of Pharmacy (B. Pharm) degree from the Department of Pharmaceutical Sciences at Dibrugarh University in 2011, securing a commendable 68.02% marks. Demonstrating her commitment to further specialization, she qualified for the Graduate Pharmacy Aptitude Test (GPAT) in 2011, obtaining an All India Rank of 9000, which facilitated her pursuit of a Master of Pharmacy (M. Pharm) with a specialization in Pharmacology. She completed her M. Pharm in 2013 with an impressive CGPA of 8.13 (81.3%). Dr. Borah’s academic pursuits culminated in a Doctor of Philosophy (Ph.D.) degree from Dibrugarh University in 2021. Her doctoral research focused on investigating the neuroprotective efficacy of Curcuma caesia Roxb., a plant indigenous to Northeast India, under the guidance of Prof. (Dr.) Hemanta Kumar Sharma. This progression underscores her dedication to advancing her expertise in pharmaceutical sciences and contributing to indigenous medicinal research.

Professional Experience

Dr. Borah’s professional trajectory spans over eight years, characterized by a blend of teaching, research, and administrative roles. She has held the position of Vice Principal and Associate Professor at the School of Pharmaceutical Sciences, University of Science and Technology, Meghalaya (USTM). In this capacity, she has been instrumental in coordinating the Internal Quality Assurance Cell (IQAC), managing social media outreach, convening departmental committee meetings, and serving as the member secretary of the School Research Committee. Her role also encompassed organizing events and seminars, reflecting her commitment to fostering an environment conducive to academic excellence and research innovation. Dr. Borah’s leadership and dedication have significantly contributed to the growth and development of the pharmaceutical sciences department at USTM, enhancing both its academic standards and research output.

Research Interests

Dr. Borah’s research interests are deeply rooted in the exploration of natural products and their pharmacological applications. She has extensively studied the neuroprotective properties of indigenous plants from Northeast India, with a particular focus on Curcuma caesia Roxb. Her work delves into the phytochemical analysis and therapeutic potential of these plants in managing neurodegenerative diseases such as Alzheimer’s. Additionally, Dr. Borah has investigated the antioxidant and antimicrobial properties of various medicinal plants, aiming to identify bioactive compounds that could serve as leads for novel therapeutic agents. Her interdisciplinary approach bridges the gap between traditional ethnomedicine and modern pharmacological research, contributing to the development of alternative therapeutic strategies derived from natural sources.

Research Skills

Dr. Borah possesses a comprehensive skill set that underpins her research endeavors. Her expertise includes phytochemical screening, chromatographic techniques, and molecular docking studies, which she employs to elucidate the bioactive constituents of medicinal plants and their mechanisms of action. She is proficient in conducting in vitro and in vivo pharmacological assays to assess the efficacy of natural compounds in various disease models. Dr. Borah’s methodological rigor is complemented by her ability to integrate traditional knowledge with contemporary scientific methodologies, enabling her to explore the therapeutic potential of ethnomedicinal plants systematically. Her skills in data analysis and interpretation further enhance the robustness of her research findings, contributing to the field of natural product pharmacology.

Awards and Honors

Throughout her career, Dr. Borah has been the recipient of several prestigious awards that recognize her contributions to pharmaceutical sciences and research. Notably, she was honored with the International Young Scientist Award in 2019 by the International Science Community Association, acknowledging her innovative research and potential as a burgeoning scientist. In 2021, she received the Young Woman Scientist Award at the 5th International Conference on “Advances in Agriculture, Environmental and Biosciences for Sustainable Development,” organized by the Agro Environmental Development Society. Her excellence in research was further recognized with the Award of Excellence in Research by the Northeast Research Conclave at USTM. Additionally, Dr. Borah was bestowed with the Best Teacher Award in 2023 by the Research India Foundation in Bhubaneswar, Odisha, underscoring her dedication to education and mentorship in the pharmaceutical sciences.

Conclusion

Dr. Sudarshana Borah exemplifies a harmonious blend of academic excellence, research innovation, and leadership in the field of pharmaceutical sciences. Her unwavering commitment to exploring the therapeutic potential of natural products, particularly those indigenous to Northeast India, has significantly contributed to the understanding and development of alternative medicinal therapies. Dr. Borah’s roles in academia, encompassing both teaching and administrative responsibilities, reflect her dedication to nurturing future generations of pharmaceutical professionals. Her accolades and extensive research portfolio stand as a testament to her impact on the scientific community. As she continues her career, Dr. Borah remains poised to make further strides in pharmaceutical research and education, fostering innovation and excellence in her field.

Publication Top Notes

  1. Regulation of anthocyanin synthesis in red lettuce in plant factory conditions: A review

    • Authors: H. Anum, K. Li, J. Tabusam, S.A.A. Saleh, R. Cheng, Y. Tong
    • Year: 2024
    • Journal: Food Chemistry
    • Impact Factor (IF): 8.85
  2. Improving plant growth, anthocyanin production and oxidative status of red lettuce (Lactuca sativa cv. Lolla Rossa) by optimizing red-to-blue light ratio with a constant green light fraction in a plant factory

    • Authors: H. Anum, R. Cheng, Y. Tong
    • Year: 2024
    • Journal: Scientia Horticulturae
    • Impact Factor (IF): 4.4
  3. Different Preharvest Diseases in Garlic and Their Eco-Friendly Management Strategies

    • Authors: H. Anum, Y. Tong, R. Cheng
    • Year: 2024
    • Journal: Plants
    • Impact Factor (IF): 4.4
  4. Modernizing Rural Water Governance: A Systematic Review of Transitions, Dynamics, Influential Factors, and Challenges

    • Authors: H. Khan, H. Anum, Z. Yan, Q. Chunjie
    • Year: 2024
    • Journal: Water Resources Management
    • Impact Factor (IF): 4.1
  5. Reveal the Mechanisms of Different Red-to-Blue Light Ratios Affecting Nutritional Quality and Growth of Pakchoi (Brassica chinensis) in Plant Factory Conditions

    • Authors: Y. Tong, H. Anum, Y. Wang, G. Sun, J. Luo, N.S. Gruda, G. Liu
    • Year: 2024
    • Journal: Frontiers in Sustainable Food Systems
    • Impact Factor (IF): 4.4
    • Status: Revision submitted
  6. Improving Biomass and Anthocyanin Accumulation in Red Lettuce (Lactuca sativa cv. ‘Lolla Rossa’) Plants via Manipulation of Red and Blue Light Spectral Compositions under Controlled Environment

    • Authors: H. Anum, X. Liang, Y. Tong, R. Cheng
    • Year: 2024
    • Journal: Journal of Plant Growth Regulation
    • Impact Factor (IF): 3.9
    • Status: Under review
  7. The Physiological, Biochemical and Molecular Mechanisms of Anthocyanins in Mitigating Abiotic Stress in Plants: A Comprehensive Review

    • Authors: H. Anum, H. Khan, R. Cheng, Y. Tong
    • Year: 2024
    • Journal: Plant Cell Reports
    • Impact Factor (IF): 5.3
    • Status: Under review
  8. Physiological and Molecular Responses of Red Lettuce to Light Spectrum Variations in a Controlled Environment

    • Authors: H. Anum, Y. Tong, R. Cheng
    • Year: 2024
    • Journal: Horticulture Research
    • Impact Factor (IF): 7.6
    • Status: Submitted

Pijus Kumar Sasmal | Medicinal Inorganic Chemistry | Best Researcher Award

Assist Prof Dr. Pijus Kumar Sasmal | Medicinal Inorganic Chemistry | Best Researcher Award

Assistant Professor of Jawaharlal Nehru University, India.

Dr. Pijus Kumar Sasmal is an Assistant Professor at the School of Physical Sciences, Jawaharlal Nehru University, New Delhi. With a Ph.D. from the Indian Institute of Science, Bangalore, and extensive postdoctoral experience at prestigious institutions like Princeton University, Rutgers University, and Philipps Universität Marburg, his research spans the interface of chemistry and biology. Dr. Sasmal’s work focuses on the design and synthesis of novel organic and inorganic compounds for applications in chemical biology and medicinal therapeutics, including targeted metal-based anticancer and antimicrobial agents, bioorthogonal chemistry, and photoactivatable prodrugs. He has published 31 research articles, with an h-index of 17 and over 1,400 citations. His contributions have earned him several awards, including the CRSI Young Scientist Award and the Early Career Research Award from SERB-DST. Dr. Sasmal’s innovative research positions him as a leading figure in his field, with significant potential for future advancements.

Profile
Education

Dr. Pijus Kumar Sasmal is a distinguished academic with a strong foundation in chemistry. He completed his Ph.D. in Inorganic and Physical Chemistry from the prestigious Indian Institute of Science (IISc), Bangalore, in April 2010. His doctoral research, under the guidance of Prof. Akhil R. Chakravarty, focused on the chemistry of oxovanadium(IV) complexes and their photoinduced cytotoxicity and DNA cleavage activity, which set the stage for his future work in chemical biology and medicinal therapeutics. Prior to his Ph.D., Dr. Sasmal earned his M.Sc. in Chemistry from the Indian Institute of Technology (IIT), Guwahati, in 2005, where he conducted research on the synthesis of β-arylvinylbromides via brominative decarboxylation under the supervision of Prof. Bhisma K. Patel. His academic journey began with a B.Sc. in Chemistry (Honors) from Midnapore College, Vidyasagar University, West Bengal, which he completed in 2003.

Professional Experience

Dr. Pijus Kumar Sasmal is an accomplished Assistant Professor at the School of Physical Sciences, Jawaharlal Nehru University (JNU), New Delhi, where he has been serving since October 2015. With a strong foundation in chemistry and chemical biology, Dr. Sasmal’s expertise extends to cutting-edge research in the design and synthesis of novel organic and inorganic compounds for applications in chemical biology and medicinal therapeutics. Prior to his current role, he gained extensive international experience through postdoctoral fellowships at prestigious institutions, including Princeton University and Rutgers University in the USA, as well as Philipps Universität Marburg in Germany. His research during these fellowships focused on advanced topics such as polymeric nanoparticles for targeted drug delivery, hydrogel-nanoparticle hybrid scaffolds, and metal complex catalysis within living biological systems. Dr. Sasmal’s professional journey reflects his dedication to advancing the frontiers of chemical and biological research.

Research Interest

Dr. Pijus Kumar Sasmal’s research bridges the disciplines of chemistry and biology, with a focus on the design and synthesis of novel organic and inorganic compounds for biomedical applications. His research interests encompass the development of targeted metal-based anticancer and antimicrobial agents, which are tailored to enhance therapeutic efficacy and minimize side effects. Dr. Sasmal also investigates metal-catalyzed bioorthogonal chemistry within living cells, aiming to achieve precise chemical transformations without interfering with native biological processes. Additionally, his work explores the creation of photoactivatable prodrugs that allow for site-selective and controlled drug activation within cells. Another key area of his research involves the development of metal complexes as biosensors for detecting biologically important molecules, contributing to advancements in diagnostics and therapeutic monitoring. Overall, Dr. Sasmal’s research is driven by the goal of integrating chemical innovation with biological systems to address critical challenges in medicine.

Research Skills

Dr. Pijus Kumar Sasmal is an accomplished researcher with extensive expertise in the interdisciplinary field of chemistry and biology. His research skills encompass the design and synthesis of novel organic and inorganic compounds, particularly metal-based agents, for applications in chemical biology and medicinal therapeutics. Dr. Sasmal has a strong command over metal-catalyzed bioorthogonal chemistry, photoactivatable prodrugs, and biosensors for detecting biologically significant molecules. His experience in targeted drug delivery and imaging applications through polymeric nanoparticles and hydrogel-nanoparticle hybrid scaffolds further highlights his innovative approach to addressing complex biological challenges. Dr. Sasmal’s ability to integrate chemistry with biological systems, coupled with his proficiency in advanced spectroscopic and imaging techniques, has enabled him to make significant contributions to the development of anticancer and antimicrobial agents. His research is well-documented, with numerous high-impact publications, demonstrating his capacity for leading cutting-edge research in chemical biology.

 Awards and Recognition

Dr. Pijus Kumar Sasmal, an esteemed Assistant Professor at Jawaharlal Nehru University, has garnered significant recognition for his contributions to the field of chemistry. Among his notable accolades is the prestigious CRSI Young Scientist Award in February 2023, highlighting his exceptional research achievements. He was also honored with the Early Career Research Award by SERB-DST in 2016, a testament to his promising work in the early stages of his career. Additionally, Dr. Sasmal received a Start-Up Grant from the University Grants Commission (UGC) in 2016, further supporting his innovative research endeavors. His doctoral work earned him the Best Ph.D. Thesis Award for the academic year 2010-2011 from the Department of Inorganic and Physical Chemistry at IISc Bangalore. His dedication to research has been consistently recognized, reflecting his outstanding contributions to the advancement of chemical sciences.

Conclusion

Dr. Pijus Kumar Sasmal is a highly qualified candidate for the Research for Best Researcher Award. His significant contributions to chemical biology and medicinal chemistry, coupled with prestigious awards and a robust publication record, highlight his excellence as a researcher. To further strengthen his candidacy, enhancing the visibility and application of his research through patents, expanding leadership roles, and diversifying his publication outlets could be beneficial. Overall, his achievements and ongoing research efforts make him a strong contender for this award.

Publications Top Notes

  • Organoiridium-catalyzed bioorthogonal chemistry
    • Authors: Chauhan, D., Prasad, P., Sasmal, P.K.
    • Journal: Coordination Chemistry Reviews
    • Year: 2024
  • Nitrodopamine modified MnO2 NS-MoS2QDs hybrid nanocomposite for the extracellular and intracellular detection of glutathione
    • Authors: Sivakumar, G., Gupta, A., Babu, A., Sasmal, P.K., Maji, S.
    • Journal: Journal of Materials Chemistry B
    • Year: 2024
    • Citations: 4
  • Multifunctional Iridium(III)-Platinum(IV) Conjugates as Potent Anticancer Theranostic Agents
    • Authors: Gupta, A., Pandey, A.K., Mondal, T., Bhattacharya, J., Sasmal, P.K.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2023
    • Citations: 6
  • Development of Mitochondria Targeting AIE-Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents
    • Authors: Kumari, G., Gupta, A., Sah, R.K., Singh, S., Sasmal, P.K.
    • Journal: Advanced Healthcare Materials
    • Year: 2023
    • Citations: 7
  • Visible and NIR light photoactivatable o-hydroxycinnamate system for efficient drug release with fluorescence monitoring
    • Authors: Gupta, A., Singh, N., Gautam, A., Kumar, S., Sasmal, P.K.
    • Journal: RSC Medicinal Chemistry
    • Year: 2023
    • Citations: 4
  • COVID-19 detection using AIE-active iridium complexes
    • Authors: Gupta, A., Adarsh, T., Manchanda, V., Sasmal, P.K., Gupta, S.
    • Journal: Dalton Transactions
    • Year: 2023
    • Citations: 6
  • AIE-active cyclometalated iridium(iii) complexes for the detection of lipopolysaccharides and wash-free imaging of bacteria
    • Authors: Gautam, A., Gupta, A., Prasad, P., Sasmal, P.K.
    • Journal: Dalton Transactions
    • Year: 2023 (Article in Press)
    • Citations: 8
  • Algal Biomass-Loaded Hydrogel Scaffolds as a Biomimetic Platform with Antibacterial and Wound Healing Activities
    • Authors: Agarwal, A., Kumar, A., Garg, P., Chowdhury, C., Mukherjee, M.
    • Journal: ACS Applied Polymer Materials
    • Year: 2022
    • Citations: 4
  • Photoactivatable o-Hydroxycinnamic Platforms for Bioimaging and Therapeutic Release
    • Authors: Gupta, A., Gautam, A., Sasmal, P.K.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2022
    • Citations: 3
  • Mitochondria-Targeted Photoactivatable Real-Time Monitoring of a Controlled Drug Delivery Platform
    • Authors: Singh, N., Gupta, A., Prasad, P., Gupta, S., Sasmal, P.K.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2021
    • Citations: 12

 

Mehlika Dilek Altıntop | Medicinal Chemistry | Women Researcher Award

Dr. Mehlika Dilek Altıntop | Medicinal Chemistry| Women Researcher Award

Professor Doctorate of Anadolu University, Faculty of Pharmacy, Eskişehir, Turkey.

Mehlika Dilek Altıntop is a researcher specializing in the synthesis of bioactive compounds with therapeutic potential for cancer and metabolic disorders. Her work focuses on designing and evaluating enzyme inhibitors, particularly aldose reductase inhibitors for diabetes treatment. In pharmaceutical chemistry, she investigates new chemical entities with antimicrobial and anticancer activities. Altıntop also explores molecular hybridization to enhance biological activity and is involved in drug development, including the creation of innovative compounds like triazolothiadiazine derivatives. Her research contributes significantly to advancing treatment options and improving therapeutic outcomes.

Profile

Education:

Mehlika Dilek Altıntop’s educational journey began at İkieylül Elementary School, where she completed her primary education from 1991 to 1996. She then attended Eskişehir Anatolian High School for her secondary and high school education from 1996 to 2003. Pursuing higher education, she enrolled at Anadolu University, Faculty of Pharmacy, graduating with her undergraduate degree in 2007. She continued her academic career at Anadolu University, where she completed a Master’s Degree with Thesis in Pharmaceutical Chemistry at the Graduate School of Health Sciences between 2007 and 2009. Subsequently, she earned her Doctoral Degree in Pharmaceutical Chemistry from the same institution, graduating in 2012. Additionally, she possesses an excellent command of English, which complements her academic and professional expertise.

Academic Titles:

Prof. Dr. Mehlika Dilek Altıntop has had a distinguished career at Anadolu University, Faculty of Pharmacy. She began as a Research Assistant from 2010 to 2012, where she gained foundational experience in pharmaceutical research. She then advanced to the role of Research Assistant Doctor from 2012 to 2014, further deepening her expertise. Her career continued to progress as she took on the position of Assistant Professor Doctor from 2014 to 2015, during which she began to establish her reputation in the field. In 2015, she was promoted to Associate Professor Doctor, a role she held until 2020. Since 2020, Prof. Dr. Altıntop has served as a Professor Doctor at Anadolu University, where she continues to contribute significantly to the field of pharmacy through both her research and teaching activities. Her career reflects a consistent trajectory of academic growth and leadership.

Awards:

Prof. Dr. Mehlika Dilek Altıntop has received numerous accolades throughout her distinguished career. In 2007, she was honored with the Anadolu University Faculty of Pharmacy Championship Award and the Graduate Scholarship from The Scientific and Technological Research Council of Turkey. Her exceptional contributions were further recognized with the Anadolu University Science and Technology Encouragement Award and several Article Performance Awards from 2014 to 2018. She achieved the Gold and Platinum Article Performance Awards in 2015 and was named Outstanding Reviewer by the European Journal of Medicinal Chemistry in 2016. In 2019, she received the Turkish Pharmacists’ Association Academy of Pharmacy Encouragement Award. Prof. Altıntop was awarded the Anadolu University Academic Outstanding Success Award in 2020 and 2021 and recognized as the Outstanding Woman Researcher in Pharmaceutical Chemistry at VIWA 2021. Her invention, “Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer,” earned a Silver Medal at ISIF’21. Her top-cited articles in Archiv der Pharmazie and Open Chemistry further highlight her impactful research.

 

Dr. Mehlika Dilek Altıntop’s research focuses on medicinal chemistry, with a particular emphasis on:

Mehlika Dilek Altıntop’s research is centered on the synthesis and development of bioactive compounds with significant therapeutic potential, particularly for cancer and metabolic disorders. Her work involves designing and evaluating enzyme inhibitors, such as aldose reductase inhibitors, to address conditions like diabetes. In pharmaceutical chemistry, she investigates new chemical entities and their pharmacological effects, including antimicrobial and anticancer properties. A key aspect of her research is molecular hybridization, where she combines different molecular scaffolds to enhance biological activity. Her focus on drug development includes the creation and testing of innovative drugs, exemplified by her work on triazolothiadiazine derivatives and other novel compounds. Altıntop’s contributions aim to advance therapeutic options and improve treatment outcomes across a range of medical conditions.

PUBLICATION TOP NOTES:

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    European Journal of Medicinal Chemistry, 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    ACS Omega, 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    Altıntop, M.D., Cantürk, Z., Özdemir, A.
    ACS Omega, 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    ACS Omega, 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    Archiv der Pharmazie, 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    Drug Development Research, 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    International Journal of Molecular Sciences, 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    Altıntop, M.D., Temel, H.E., Özdemir, A.
    Journal of the Serbian Chemical Society, 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    European Journal of Medicinal Chemistry, 2022

 

 

 

Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Dr Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Professor Doctorate, Anadolu University ,Turkey.

Ahmet ÖZDEMİR, born on July 24, 1972, in Muğla, Turkey, is a Professor of Pharmaceutical Chemistry at Anadolu University, where he has been a faculty member since 1997. He earned his undergraduate degree in Pharmacy from Anadolu University (1990-1994), followed by an M.Sc. in Pharmaceutical Chemistry (1995-1996) and a Ph.D. in the same field (1996-2004), with research focusing on the synthesis and biological activities of novel compounds. Dr. ÖZDEMİR has held various academic positions at Anadolu University, advancing from Research Assistant to Professor. He has also served in administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty’s Department of Health Administration. His research is well-regarded, earning him multiple awards, including the Anadolu University Article Performance Award and the ISIF’21 Silver Medal for his work on targeted novel triazolothiadiazine derivatives for lung cancer treatment.

Profile:

Education

Prof. Dr. Ahmet Özdemir’s educational journey began at Salihli Cumhuriyet Elementary School, where he completed his primary education from 1978 to 1983. He continued his secondary education at Salihli 50. Yıl Secondary School from 1983 to 1986, and then attended Salihli High School from 1986 to 1989, where he completed his high school education. Prof. Dr. Özdemir pursued his undergraduate studies at Anadolu University Faculty of Pharmacy, graduating in 1994. He furthered his education with a Master’s Degree in Pharmaceutical Chemistry at Anadolu University’s Graduate School of Health Sciences from 1995 to 1996, where he completed his thesis. He continued at Anadolu University for his Doctoral Degree in Pharmaceutical Chemistry, which he achieved in 2004. Additionally, he possesses intermediate proficiency in English, which complements his academic background and research expertise.

Academic Titles

Prof. Dr. Ahmet Özdemir’s academic career at Anadolu University’s Faculty of Pharmacy spans several roles and achievements. He began his journey as a Research Assistant in 1997, a position he held until 2004. Following this, he advanced to the role of Research Assistant Doctor, continuing his work at the same institution from 2004 to 2005. Dr. Özdemir was then appointed as a Lecturer from 2005 to 2007, showcasing his growing expertise in the field. His contributions were recognized with a promotion to Assistant Professor Doctor, a role he embraced from 2007 to 2010. His exceptional work led to his promotion to Associate Professor Doctor, a position he held from 2010 to 2015. Since 2015, Prof. Dr. Özdemir has served as Professor Doctor, continuing to make significant contributions to the Faculty of Pharmacy and the broader academic community.

Awards

Prof. Dr. Ahmet Özdemir has received several prestigious awards for his academic and research contributions. In 2014, he was honored with the Anadolu University Article Performance Award. His outstanding achievements continued with the Anadolu University Gold Article Performance Award and the Anadolu University Platinum Article Performance Award in 2015. He maintained a high standard of excellence, receiving the Anadolu University Article Performance Award annually from 2016 to 2018. In 2019, Dr. Özdemir was recognized with the Anadolu University Academic Success Award. His consistent performance earned him the Anadolu University Article Performance Award again in 2020. Notably, in 2021, he was awarded the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for the Treatment of Lung Cancer” at the 6th Istanbul International Inventions Fair (ISIF’21). This award was shared with Assoc. Prof. Dr. Belgin Sever, Prof. Dr. Mehlika Dilek Altintop, and Prof. Dr. Gülşen Akalın Çiftçi.

Research Focus

Prof. Dr. Ahmet Özdemir’s research is dedicated to the field of medicinal chemistry, with a keen focus on several key areas. He specializes in the synthesis of bioactive compounds, aiming to develop novel chemical entities with potential therapeutic uses, particularly targeting antifungal and antibacterial applications. His work in pharmaceutical chemistry involves investigating the physicochemical properties of these compounds, which has significant implications for drug design and efficacy. Dr. Özdemir also explores antimicrobial agents, focusing on the synthesis and evaluation of compounds designed to combat bacterial and fungal pathogens. In the realm of drug design and development, he examines structure-activity relationships to create effective and selective pharmaceutical agents. Additionally, his contributions extend to invention and innovation, where he develops novel chemical derivatives, such as triazolothiadiazine derivatives, for potential applications in treating diseases like lung cancer.

Publications

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    • Authors: Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    • Year: 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    • Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    • Year: 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    • Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    • Year: 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    • Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    • Year: 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    • Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    • Year: 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    • Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    • Year: 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    • Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    • Year: 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    • Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
    • Year: 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    • Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    • Year: 2022
  10. “A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition”
    • Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
    • Year: 2022